MTOR and cancer: In the case of HNSCC, activation of the PI3K/mTOR signaling circuitry is the most frequently dysregulated signaling pathway6,8,11, and this reliance on PI3K/mTOR signaling for tumor growth may in turn expose a key cancer vulnerability that can be exploited therapeutically.